Verrica Pharmaceuticals VRCA Cash Flow Statement (2017-2026)

NASDAQ VRCA
$4.97 +0.11 (+2.24%)
As of: Aug 21, 2026 · 10:24 AM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-12.84M-10.63M-8.47M-10.48M1.50M-6.31M-10.89M-10.99M-24.75M-24.18M-2706.93M-17.18M-30.93M-12.94M-10.00M-1.17M-4.09M-10.38M-10.54M-14.51M
Depreciation and Depletion (Quarter)
0.05M0.14M0.10M0.10M0.13M0.18M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.01M0.05M0.04M0.02M0.01M0.02M0.01M
Share-based Compensation (Quarter)
1.48M1.32M1.32M1.08M1.41M1.17M1.09M1.54M9.66M2.08M2.07M2.23M2.11M0.76M1.03M0.89M0.72M0.69M0.90M1.21M
Cash from Operations (Quarter)
-10.60M-8.70M-8.34M-7.18M1.82M-4.95M-4.59M-4.67M-14.81M-14.51M-19.95M-16.36M-8.56M-16.06M-12.68M-10.04M9.72M-4.60M-9.20M-9.24M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.04M-0.05M-0.05M-0.03M-0.02M0.10M0.02M0.14M0.16M0.19M0.62M0.08M0.08M0.09M-0.02M0.10M0.11M
Amortization of Deferred Charges (Quarter)
-0.56M0.06M0.30M-0.17M0.07M0.07M0.07M-0.07M0.34M-0.05M0.48M0.52M-0.75M0.06M0.67M-0.52M1.93M-1.78M0.08M0.08M
Depreciation & Amortization (CF) (Quarter)
0.05M0.14M0.10M0.10M0.13M0.18M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.01M0.05M0.04M0.02M0.01M0.02M0.01M
Change in Working Capital
Change in Receivables (Quarter)
3.95M-0.09M2.75M3.02M-10.18M0.20M5.56M3.59M-2.15M-1.79M2.46M3.21M
Change in Inventory (Quarter)
0.06M-0.22M-0.26M0.74M
Change in Account Payables (Quarter)
0.09M-0.03M-0.31M0.18M-0.58M0.37M0.01M1.49M0.12M0.58M0.05M-1.38M-0.17M0.93M-0.45M0.88M-0.74M0.49M0.12M-0.59M
Change in Accured Expenses (Quarter)
0.67M-0.70M-1.43M0.55M0.55M0.07M-0.93M1.65M5.46M5.12M1.97M2.02M0.90M-5.18M0.97M-1.38M-0.50M-0.40M-0.59M2.30M
Other Working Capital Changes (Quarter)
-0.28M-0.54M-0.51M0.78M0.72M-1.27M-1.62M1.88M0.42M1.27M-1.27M1.50M-0.37M-0.55M-0.27M2.09M-1.01M-0.43M0.25M
Investing Activities
Capital Expenditures (Quarter)
0.04M0.24M0.01M0.15M0.08M0.07M0.01M0.06M0.07M0.23M0.01M0.02M
Change in Acquisitions & Divestments (Quarter)
19.20M14.20M47.51M2.49M2.01M7.00M
Cash from Investing Activities (Quarter)
6.29M4.01M43.01M2.21M2.07M6.75M-0.01M-0.06M-0.07M-0.23M-0.01M-0.02M0.01M
Financing Activities
Other financing activities (Quarter)
0.04M0.01M0.00M0.15M0.00M
Cash from Financing Activities (Quarter)
0.04M-0.00M-0.02M-0.00M-16.85M30.28M-0.08M44.04M-0.03M-0.66M-0.64M-0.40M39.43M-4.06M-4.16M-3.98M13.64M-0.12M-0.13M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
-0.00M26.90M30.30M
Additional items
Change in Cash (Quarter)
-4.26M-4.69M34.66M-4.98M-12.96M1.80M25.68M-4.81M29.17M-14.76M-20.61M-17.01M-8.97M23.37M-16.73M-14.20M5.70M9.05M-9.28M-9.40M
Free Cash Flow (Quarter)
-10.64M-8.94M-8.35M-7.33M1.75M-5.02M-4.60M-4.73M-14.88M-14.73M-19.95M-16.37M-8.57M-16.06M-12.68M-10.04M9.72M-4.60M-9.20M-9.24M
Net Cash Flow (Quarter)
-4.26M-4.69M34.66M-4.98M-12.96M1.80M25.68M-4.81M29.17M-14.76M-20.61M-17.01M-8.97M23.37M-16.73M-14.20M5.74M9.04M-9.32M-9.37M